Over the last 12 months, its price rose by percent. Looking ahead, we forecast Viatris Inc to be priced at by the end of this quarter and at Viatris Inc. (NASDAQ: VTRS) today announced that on August 5, , its Board of Directors declared a quarterly dividend of $ per share for each issued and. VTRS | Complete Viatris Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Viatris Inc.'s stock symbol is VTRS and currently trades under NASDAQ. It's current price per share is approximately $ What. The 15 analysts offering price forecasts for Viatris have a median target of , with a high estimate of and a low estimate of The median.
The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to. Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. According to 3 analysts, the average rating for VTRS stock is "Hold." The month stock price forecast is $, which is an increase of % from the latest. The intrinsic value of one VTRS stock under the Base Case scenario is USD. Compared to the current market price of USD, Viatris Inc is Undervalued. The current price of VTRS is USD — it has increased by % in the past 24 hours. Watch Viatris Inc. stock price performance more closely on the chart. No-moat Viatris reported decent second-quarter results that came in slightly ahead of our expectations. After updating our model and accounting for time. Viatris reported mixed second-quarter results, with a net loss contrasting new product growth and strategic divestitures. Is Viatris a Great Dividend Stock. On average, Wall Street analysts predict that Viatris's share price could reach $ by Jul 19, The average Viatris stock price prediction forecasts a. Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. VTRS Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Trading at good value compared to. The stock price has increased by +% in the last 52 weeks. The beta is , so Viatris's price volatility has been similar to the market average. Beta (5Y).
The Viatris Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. In the current month, VTRS has received 0 Buy Ratings, 1 Hold Ratings, and 4 Sell Ratings. VTRS average Analyst price target in the past 3 months is $ Average Recommendation, Hold ; Average Target Price, ; Number Of Ratings, 11 ; FY Report Date, 12/ ; Last Quarter's Earnings, The intrinsic value of one VTRS stock under the Base Case scenario is USD. Compared to the current market price of USD, Viatris Inc is Undervalued. Key Stats · Market CapB · Shares OutB · 10 Day Average VolumeM · Dividend · Dividend Yield% · Beta · YTD % Change Get the latest Viatris Inc (VTRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading. The stock performance, investment calculator and stock history below are provided as tools for current and prospective Viatris investors. Viatris (VTRS) has a Smart Score of 1 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. Find the latest analyst research, reports, and ratings for Viatris Inc. Common Stock (VTRS) at kvant-rzn.ru
Viatris Inc. (kvant-rzn.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Viatris Inc. | Nasdaq: VTRS | Nasdaq. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ VTRS will report FY earnings on 03/03/ Yearly Estimates. Viatris Market Cap. Viatris has a market cap or net worth of $ billion as of September 3, Its market cap has increased by % in one year. On average, Wall Street analysts predict that Viatris's share price could reach $ by Jul 19, The average Viatris stock price prediction forecasts a. Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets.
Market. Shares outstanding. B Market cap. $B Enterprise value. $B Valuations. Price to earnings (P/E). N/A · Per share. EPS. -$ Free cash. Viatris Inc Frequently Asked Questions · What is Viatris Inc(VTRS)'s stock price today? The current price of VTRS is $ · When is next earnings date of. Viatris (VTRS) · Viatris (VTRS) - Develops generic and branded drugs for a diverse range of treatments from cardiovascular health to oncology. · You're invited. How to buy Viatris stock on Public · Sign up for a brokerage account on Public · Add funds to your Public account · Choose how much you'd like to invest in. View the latest Viatris Inc. (VTRS) stock price, news, historical charts, analyst ratings and financial information from WSJ.